MarketInOut Stock Screener Log In | Sign Up

Amgen Inc

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Amgen Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization222,173 mln
Float539 mln
Earnings Date11/03/2026

EPS

13.90
Robust

P / E

30.44
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.53
Likely reliable

Relative Strength

97 / 100
Top performer

Debt / Equity

4.90
Highly leveraged

Business Description

Founded in 1980 and based in Thousand Oaks, California, Amgen is a global biotechnology company focused on developing and producing medicines that treat serious conditions such as cancer, bone disease, heart disease, and autoimmune disorders. The company sells a wide range of products to hospitals, clinics, and pharmacies through wholesale distributors, reaching patients around the world. Amgen also works alongside partners like AstraZeneca, UCB, and BeiGene to expand its research and bring new treatments to market.

Key Fundamentals

EPS13.90
P/E30.44
ROE93.84
RPS63.08
ROIC16.40
ROA9.57
Interest Cover4.70
EBITDA, mln15,140
EV / EBITDA16.23
EV / EBIT22.07
Revenue, mln32,759
EV / Revenue7.51

Quote Details

Last 423.05
Change 12.1 (2.94%)
Open 417.85
Volume 330
Turnover 139,606
Average Volume 516.43

Financial Ratios

Pre-Tax Profit Margin27
Leverage Ratio8.18
Current Ratio1.37
Price / Book20.72
Price / Cash Flow19.94
Price / Free Cash Flow23.91
Debt / Equity4.90
Price / Sales6.37
PEG Ratio3.34

Financial Strength

Altman Z-Score2.37
Piotroski F-Score 8 / 9
Beneish M-Score-2.53
Price to Intrinsic Value1.95
Price to Lynch Fair Value2.54
Shiller PE Ratio34.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.79% 97 / 100   
1 Month 14.97% 95 / 100   
2 Months 23.52% 96 / 100   
6 Months 53.9% 98 / 100   
1 Year 70.17% 97 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog